Page last updated: 2024-08-21

indazoles and gdc-0068

indazoles has been researched along with gdc-0068 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aceto, N; Auricchio, N; Barber, P; Baselga, J; Bergamaschi, A; Bosch, A; Carey, LA; Castel, P; Elkabets, M; Ellis, H; Hazra, S; Juric, D; Kim, P; Lewis, JS; Maheswaran, S; Morse, N; Ng, T; Penault-Llorca, F; Perou, CM; Radosevic-Robin, N; Scaltriti, M; Singh, S; Tao, JJ; Viola-Villegas, NT; Vojnovic, B; Weitsman, G	1
Hamilton, BJ; Stan, RV; Tse, D	1

Other Studies

2 other study(ies) available for indazoles and gdc-0068

Article	Year
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer. Science signaling, 2014, Mar-25, Volume: 7, Issue:318 Topics: Antibodies, Monoclonal, Humanized; Blotting, Western; Cell Line, Tumor; Cetuximab; Dimerization; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Immunoglobulin G; Indazoles; Neuregulin-1; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; Receptor, ErbB-3; Signal Transduction; Sulfonamides; Triple Negative Breast Neoplasms	2014
Phorbol esters induce PLVAP expression via VEGF and additional secreted molecules in MEK1-dependent and p38, JNK and PI3K/Akt-independent manner. Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:2 Topics: Anthracenes; Autocrine Communication; Axitinib; Butadienes; Flavonoids; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Indazoles; MAP Kinase Kinase 1; MAP Kinase Kinase 4; Membrane Proteins; Nitriles; Phosphatidylinositol 3-Kinases; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; RNA, Small Interfering; Signal Transduction; Sulfonamides; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2019

Article

Year

Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer.

Science signaling, 2014, Mar-25, Volume: 7, Issue:318

Topics: Antibodies, Monoclonal, Humanized; Blotting, Western; Cell Line, Tumor; Cetuximab; Dimerization; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Immunoglobulin G; Indazoles; Neuregulin-1; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; Receptor, ErbB-3; Signal Transduction; Sulfonamides; Triple Negative Breast Neoplasms

2014

Phorbol esters induce PLVAP expression via VEGF and additional secreted molecules in MEK1-dependent and p38, JNK and PI3K/Akt-independent manner.

Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:2

Topics: Anthracenes; Autocrine Communication; Axitinib; Butadienes; Flavonoids; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Indazoles; MAP Kinase Kinase 1; MAP Kinase Kinase 4; Membrane Proteins; Nitriles; Phosphatidylinositol 3-Kinases; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; RNA, Small Interfering; Signal Transduction; Sulfonamides; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2019